Clinical Trials Logo

Filter by:
NCT ID: NCT05672680 Completed - Inguinal Hernia Clinical Trials

Transabdominal Plane (TAP) Blocks for Inguinal Hernia Repairs

Start date: December 9, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

The aim of this double-blind clinical trial is to examine outcomes and pain control after surgery in patients who underwent laparoscopic inguinal hernia repair (IHR) with the use of perioperative transabdominal plane (TAP) block. Research Question: Does transabdominal plane block improve pain when undergoing inguinal hernia repair? The endpoints include whether preoperative TAP blocks improve pain score (primary end point) and decrease opioid use (secondary endpoint) after an inguinal hernia repair. Other end points- complications after surgery.

NCT ID: NCT05672667 Completed - Clinical trials for Healthy Volunteer Study

A Pharmacokinetic Study of Intravenous and Intranasal Oxytocin in Healthy Subjects

Start date: February 27, 2023
Phase: Phase 1
Study type: Interventional

The main purpose of this study is to sample blood and model the plasma pharmacokinetics (PK) of a single dose of intravenous (IV) oxytocin and a single dose of intranasal (i.n.) oxytocin. This is an unblinded study of subjects, all of whom will receive an intravenous (IV) infusion and intranasal (i.n.) dose of oxytocin (a naturally occurring hormone that is made in the brain) with blood samples taken thereafter in order to create a formula to describe the concentrations of oxytocin in the blood over time (pharmacokinetics). In this study healthy volunteers and people are recruited for a two day study. Each study participant will have 2 IV catheters placed (one in each arm) for the day of IV oxytocin dosing and 1 IV catheter on the day of i.n. oxytocin dosing. After placement of the IV catheters, an infusion of oxytocin will be given over a 30 minute period. Blood samples will be taken after the infusion begins and several times during and after the infusion. The blood will be drawn through the IV catheter not used for the oxytocin infusion. For the intranasal oxytocin administration day, 1 IV catheter will be placed and several blood samples will be taken after administration.

NCT ID: NCT05671055 Completed - Multiple Sclerosis Clinical Trials

CogMS - A Real-world Study Into Cognitive Impairment in People With Multiple Sclerosis

Start date: January 7, 2023
Phase:
Study type: Observational

The present study will investigate the correlation between objective and subjective cognition in multiple sclerosis. The study will also investigate the impact of covariates such as fatigue and depression, the relationship with the Expanded Disability Status Scale (EDSS) and brain volumetrics as measured on magnetic resonance imaging (MRI). Additionally, the study will provide insights into patients' experiences with cognition, and the usability of the used objective cognitive assessments.

NCT ID: NCT05670639 Completed - Aging Clinical Trials

CAPABLE Care Partner Pilot Study

Start date: January 10, 2023
Phase: N/A
Study type: Interventional

This is a small-scale multi-site pilot of a supplemental enhancement called "Care Partner" to the evidence-based CAPABLE program that will involve up to 60 individuals (30 care partners and older adult dyads) and 30 professional staff in organizations currently licensed to provide CAPABLE. This is a qualitative study of a convenience sample of individuals.

NCT ID: NCT05670587 Completed - Pulmonary Fibrosis Clinical Trials

A Study in People With Pulmonary Fibrosis to Monitor Cough With a Wearable Device

Start date: January 16, 2023
Phase: N/A
Study type: Interventional

This study is open to adults aged 18 years and older who have pulmonary fibrosis with or without a known cause (or other forms of pulmonary fibrosis). The purpose of this study is to better understand coughing in people with pulmonary fibrosis. To do this, a wearable cough monitor called Strados Remote Electronic Stethoscope Platform (RESP) is used. This device will measure how often and how forceful coughing is in people with pulmonary fibrosis. All participants in the study get the device. It is placed on their skin over the chest. Participants are in the study for 3 months. During this time, they visit the study site 2 to 3 times. 4 visits are done at the participant's home by video call with the site staff. During the study, the device measures coughing over 24 hours. This is done on 4 days. Participants fill in questionnaires about their coughing and doctors regularly check participant's lung function. A breathing test that measures how well the lungs are working is performed both in the office and during home visits. The doctors also regularly check participants' health and take note of any unwanted effects. This study will also record patients' experiences using the cough monitor and video assisted breathing tests at visits 3, 4, 5 and 6 at home.

NCT ID: NCT05670223 Completed - Physical Activity Clinical Trials

Healthy Activities Improve Lives

HAIL
Start date: September 30, 2022
Phase: N/A
Study type: Interventional

The investigators have developed an online platform to support the 8-week, F&S! exercise program called the Healthy Activity Improves Lives (HAIL) online platform. The aims of this study are to conduct an open pilot trial with exit interviews (N=30) of the HAIL online platform in two racially diverse churches to evaluate its feasibility and acceptability (Hypothesis 1) as well as explore its efficacy (Hypothesis 2).

NCT ID: NCT05669924 Completed - Pain Clinical Trials

Neural Correlates of Acute Pain Dynamics

Start date: September 19, 2022
Phase: Phase 2
Study type: Interventional

This work aims to study the neural correlates and determinants of pain dynamics related to changes in a noxious stimulus.

NCT ID: NCT05669066 Completed - Knee Osteoarthritis Clinical Trials

Meditation and Opioid Consumption in Total Joint Replacement Patients Undergo Primary Total Hip and Knee Replacement

Start date: July 10, 2017
Phase: N/A
Study type: Interventional

The main purpose of this study is to look at whether meditation techniques can help reduce pain and opioid use after surgery.

NCT ID: NCT05668117 Completed - Femur Fracture Clinical Trials

RFN-Advanced Retrograde Femoral Nailing System

RFNA
Start date: February 1, 2021
Phase:
Study type: Observational

This study is a retrospective chart review of the safety and performance Standard of Care data on individuals that have previously been implanted with the femur nail of the RFNA System for the internal fixation of the femur. Demographics, medical history, primary diagnosis, mechanism of injury, type of injury, clinical and radiographic evaluation of bone consolidation, and device-related adverse events were collected. Descriptive statistics were applied to the data collected.

NCT ID: NCT05667116 Completed - Clinical trials for SARS-CoV-2, COVID-19

eVusheld Assessment reaL wORld Effectiveness at UPMC

VALOR-C19 UPMC
Start date: January 9, 2023
Phase:
Study type: Observational

An AstraZeneca-sponsored observational, electronic healthcare record (EHR)-embedded retrospective cohort study to assess the real-world effectiveness of EVUSHELD against SARS-CoV-2 infection, COVID-19-related hospitalization, and other COVID-19 related outcomes in the total EUA-eligible patient population in the University of Pittsburgh Medical Center (UPMC) Health System.